ArticleJournal of tissue engineering

Engineered extracellular vesicle-delivered TGF-β inhibitor for attenuating osteoarthritis by targeting subchondral bone.

Zhaopu Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.